Single Cell Analysis 2010: the New Frontier for 'Omics Market Report
Publisher:
Select Biosciences
Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into oblivion. ’Omics technologies are beginning to be used to analyze genes, proteins, and metabolites in single cells, and beginning to meet the significant demand in applications such as cancer biology, stem cell biology, neurobiology, synthetic biology and biofuel and drug development, where understanding and manipulating the full complexity of intracellular pathways is the Holy Grail. ’Omics-based single cell analysis is a new market opportunity with potential growth that is almost beyond belief. The market is projected to grow from $70 million in sales in 2009 to more than $575 million in 2015, according to Single Cell Analysis 2010: the New Frontier for ’Omics, a new report published by Select Biosciences and written by BioPerspectives. Report Table of Contents (TOC) [Click Here to Download PDF File]Sample Pages from the Market Report [Downloadable PDF File]
|